Charlotte Eye Ear Nose & Throat Associates, P.A. (CEENTA) · 3 weeks ago
Epic Ambulatory Analyst
Charlotte Eye Ear Nose & Throat Associates, P.A. (CEENTA) is seeking an Epic Ambulatory Analyst to support high quality patient care delivery through the analysis, design, and implementation of Epic clinical applications. The role involves providing user support, managing multiple projects, and ensuring compliance with HIPAA standards.
CommunitiesHealth CareMedical
Responsibilities
Perform analysis, design, development, and maintenance of the Epic clinical applications and related clinical information systems. Understand relevant operational workflows and apply that knowledge to decisions to software build
Proactively identify impact of changes upon other applications and downstream systems
Provide timely user support through multiple communication methods and on-site support as needed
The ability to simultaneously manage and participate in numerous projects while ensuring weekly progress and timely completion
Conduct testing and ensure test scenarios are adequately documented. Monitor behavior of recently modified components in the production environment
Maintain confidentiality and integrity of all patient medical records that are viewed or provided in accordance with HIPAA standards
Ability to meet the physical and mental demands of the position
The ability to work on-site
Predictable, reliable, and prompt attendance
Qualification
Required
High school diploma or equivalent required
Preferred
Bachelor's degree preferred
0-3 year of EpicCare Ambulatory analyst experience preferred
An active Epic (2020+) EpicCare Ambulatory certification preferred. Certification must be obtained within 3 months of hire date
Certifications relating to other Epic modules, software applications, technology infrastructure, and or clinical specializations are an advantage
Company
Charlotte Eye Ear Nose & Throat Associates, P.A. (CEENTA)
For over a hundred years, Charlotte Eye Ear Nose & Throat Associates, P.A.
Funding
Current Stage
Late StageRecent News
2025-10-28
Company data provided by crunchbase